The Introduction of Generic Aromatase Inhibitors and Treatment Adherence Among Medicare D Enrollees - Concepedia

Concepedia

Publication | Open Access

The Introduction of Generic Aromatase Inhibitors and Treatment Adherence Among Medicare D Enrollees

DOI Full Paper Access

46

Citations

32

References

2015

Year

Joan Neuner, Sailaja Kamaraju, John A. Charlson, Erica Wozniak, Elizabeth C. Smith, Alana Biggers, Alicia Smallwood, Purushottam W. Laud, Liliana E. Pezzin

JNCI Journal of the National Cancer Institute

Abstract

The introduction of generic medications attenuated the decline in adherence to AIs over three years of treatment among breast cancer survivors not receiving low-income subsidies for Medicare D coverage.

References

	Year	Citations
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer Reiki Nishimura, Tomofumi Osako, Yasuyuki Nishiyama, Oncology	2013	13.2K
Adherence to Medication Lars Osterberg, Terrence F. Blaschke New England Journal of Medicine	2005	7.8K
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials The Lancet Breast OncologyMedicineRandomised TrialsPatient-level Meta-analysisPharmacology	2011	3K
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial Christina Davies, Hongchao Pan, Jon Godwin, The Lancet Breast OncologyLong-term EffectsMedicineRandomised TrialGynecology	2012	2K
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer Dawn L. Hershman, Theresa Shao, Lawrence H. Kushi, Breast Cancer Research and Treatment NursingEarly DiscontinuationSurgical OncologyBreast OncologyMedicine	2010	868
Nonadherence to Adjuvant Tamoxifen Therapy in Women With Primary Breast Cancer Ann H. Partridge, Philip S. Wang, Eric P. Winer, Journal of Clinical Oncology	2003	671
A Decade of Direct-to-Consumer Advertising of Prescription Drugs Julie M. Donohue, Marisa Cevasco, Meredith B. Rosenthal New England Journal of Medicine	2007	512
Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia Stacie B. Dusetzina, Aaron N. Winn, Gregory A. Abel, Journal of Clinical Oncology	2013	489
Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer Ann H. Partridge, Andrea LaFountain, Erica L. Mayer, Journal of Clinical Oncology	2008	483
NCCN Task Force Report: Oral Chemotherapy Saul N. Weingart, Elizabeth Brown, Peter B. Bach, Journal of the National Comprehensive Cancer Network	2008	432

Page 1